Evidence map›Paper›PMID 36136626›Full record

ArticleTropical medicine and infectious disease2022

Assessing Public Awareness of the Malaria Vaccine in Sub-Saharan Africa.

Taiwo Opeyemi Aremu, Chinar Singhal, Oluwafemi Augustine Ajibola, Emmanuel Agyin-Frimpong, Akua Asantewaa Appiah-Num Safo, Maduabuchi Romanus Ihekoronye, Stella Esther Nabirye, Olihe Nnenna Okoro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Taiwo Opeyemi AremuDepartment of Pharmaceutical Care & Health Systems (PCHS), College of Pharmacy, University of Minnesota, 308 Harvard Street SE, Minneapolis, MN 55455, USA.ORCID 0000-0002-9584-6468
Chinar SinghalDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, 300 West Bank Office Building, 1300 S. 2nd Street, Minneapolis, MN 55454, USA.
Oluwafemi Augustine AjibolaDepartment of Pulmonary/Critical Care, Louisiana State University Health Sciences Center New Orleans, 1901 Perdido Street, Suite 3205, New Orleans, LA 70112, USA.
Emmanuel Agyin-FrimpongDepartment of Medicine, Korle-Bu Teaching Hospital, Guggisberg Avenue, Accra KB77, Ghana.
Akua Asantewaa Appiah-Num SafoDepartment of Pharmaceutical Care & Health Systems (PCHS), College of Pharmacy, University of Minnesota, 308 Harvard Street SE, Minneapolis, MN 55455, USA.ORCID 0000-0003-1669-0360
Maduabuchi Romanus IhekoronyeDepartment of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife 220101, Nigeria.
Stella Esther NabiryeDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Old Mulago Hill Road, Kampala 7072, Uganda.
Olihe Nnenna OkoroDepartment of Pharmacy Practice & Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN 55812, USA.
University of Minnesota · USKorle Bu Teaching Hospital · GHLouisiana State University Health Sciences Center New Orleans · USMakerere University · UGObafemi Awolowo University · NGUniversity of Minnesota, Duluth · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria infection remains one of the leading causes of death in sub-Saharan Africa. Over the years, several measures have been implemented for the prevention of malaria, including vector control with insecticide-treated nets, indoor residual spraying, and seasonal or traveling prophylactics. In 2021, the World Health Organization (WHO) approved the use of the malaria vaccine in children. We conducted a cross-sectional survey study in three sub-Saharan African countries-Uganda, Ghana, and Nigeria-to assess public awareness of the malaria vaccine among the residents of these countries.

methodA cross-sectional, web-based survey was conducted between time January 2022 and April 2022 using Qualtrics

resultOverall, there was significant association between the level of education and public awareness of the malaria vaccine in each of the countries studied. Gender and place of residence were associated with awareness in Nigeria and Uganda, while younger respondents were more likely to be aware of the malaria vaccine in Ghana.

conclusionGiven the negative impact of lack of awareness and knowledge, misinformation and conspiracy theories on immunization programs, public health campaigns preceding the population-wide roll-out of the novel malaria vaccine should target the less-educated, and those residing in more rural areas, while assuring equitable access to the malaria vaccine across sub-Saharan Africa.

Indexed as

awarenessinfectious diseasemalariasub-Saharan Africavaccine

Identifiers

PMID36136626
PMCPMC9502832
OpenAlexW4293727717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.